Mirro M J, Manalan A S, Bailey J C, Watanabe A M
Circ Res. 1980 Dec;47(6):855-65. doi: 10.1161/01.res.47.6.855.
We studied the interaction of disopyramide, quinidine, and procainamide with cardiac muscarinic receptors. In electrophysiological experiments, the effects of disopyramide, quinidine, procainamide, and atropine were determined on spontaneously depolarizing guinea pig right atria (GPRA) both in the presence and absence of pharmacologically induced (physostigmine) cholinergic stimulation. All four agents demonstrated a concentration-dependent antagonism of the negative chronotropic effects of physostigmine. The order of anticholinergic potency was atropine greater than disopyramide greater than quinidine greater than procainamide. The ability of disopyramide to antagonize the physostigmine induced slowing was stereoselective, (+)disopyramide greater than (-)disopyramide. In contrast, the ability of quinidine to antagonize the negative chronotropic effects of physostigmine was non-stereoselective, quinidine = quinine. In parallel experiments, we studied the ability of disopyramide, quinidine, procainamide, and atropine to compete with the radiolabeled muscarinic receptor antagonist [3H] quinuclidinyl benzilate ([3H]QNB) for binding to muscarinic receptors in crude homogenates of GPRA and membrane vesicles from canine ventricular myocardium. All four agents inhibited [3H]QNB binding to muscarinic receptors. The order of anticholinergic potency determined by the receptor binding studies was identical to that determined by the physiological studies. The interaction of disopyramide with muscarinic receptors was stereoselective, (+)disopyramide > (-)disopyramide. Quinidine was only slightly more potent than quinine in inhibiting [3H]QNB binding to muscarinic receptors. Interaction of antiarrhythmic drugs with muscarinic receptors satisfied criteria for a competitive interaction. The data from this study localize the anticholinergic effects of disopyramide and quinidine to the muscarinic receptor.
我们研究了丙吡胺、奎尼丁和普鲁卡因胺与心脏毒蕈碱受体的相互作用。在电生理实验中,测定了丙吡胺、奎尼丁、普鲁卡因胺和阿托品在有无药理学诱导(毒扁豆碱)胆碱能刺激的情况下对豚鼠右心房(GPRA)自发去极化的影响。所有这四种药物均表现出对毒扁豆碱负性变时作用的浓度依赖性拮抗作用。抗胆碱能效力顺序为阿托品>丙吡胺>奎尼丁>普鲁卡因胺。丙吡胺拮抗毒扁豆碱诱导的心率减慢的能力具有立体选择性,(+)丙吡胺>(-)丙吡胺。相比之下,奎尼丁拮抗毒扁豆碱负性变时作用的能力无立体选择性,奎尼丁=奎宁。在平行实验中,我们研究了丙吡胺、奎尼丁、普鲁卡因胺和阿托品与放射性标记的毒蕈碱受体拮抗剂[3H]喹核醇基苯甲酸酯([3H]QNB)竞争结合GPRA粗匀浆和犬心室肌膜囊泡中毒蕈碱受体的能力。所有这四种药物均抑制[3H]QNB与毒蕈碱受体的结合。受体结合研究确定的抗胆碱能效力顺序与生理学研究确定的顺序相同。丙吡胺与毒蕈碱受体的相互作用具有立体选择性,(+)丙吡胺>(-)丙吡胺。在抑制[3H]QNB与毒蕈碱受体结合方面,奎尼丁仅比奎宁稍强。抗心律失常药物与毒蕈碱受体的相互作用符合竞争性相互作用的标准。本研究的数据将丙吡胺和奎尼丁的抗胆碱能作用定位到毒蕈碱受体。